ALYFTREK
Active substance: VANZACAFTOR, TEZACAFTOR, DEUTIVACAFTOR
TABLET, FILM COATED · VANZACAFTOR 4 mg/1, TEZACAFTOR 20 mg/1, DEUTIVACAFTOR 50 mg/1
United StatesActive
Marketing holder: Vertex Pharmaceuticals Incorporated
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- VANZACAFTOR · 4 mg/1
- TEZACAFTOR · 20 mg/1
- DEUTIVACAFTOR · 50 mg/1
Registration
- Registration number
- 51167-135
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 51167-135 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 51167-135 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 51167-135 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 51167-135 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 51167-135 · Verified 2026-10-09 · open in source